Feature Review
CRISPR-Cas9 Mediated Gene Editing in Tilapia: Enhancing Growth Rates and Disease Resistance
Author Correspondence author
Genomics and Applied Biology, 2024, Vol. 15, No. 2 doi: 10.5376/gab.2024.15.0012
Received: 18 Feb., 2024 Accepted: 25 Mar., 2024 Published: 08 Apr., 2024
Liang C., Lu Y., and Mai R.D., 2024, CRISPR-Cas9 mediated gene editing in tilapia: enhancing growth rates and disease resistance, Genomics and Applied Biology, 15(2): 99-106 (doi: 10.5376/gab.2024.15.0012)
CRISPR-Cas9 mediated gene editing has emerged as a transformative tool in aquaculture, offering precise genetic modifications to improve key traits in fish species such as tilapia. This study explores the potential of CRISPR-Cas9 technology to enhance growth rates and increase disease resistance in tilapia, a widely farmed species crucial to global food security. By targeting specific genes associated with growth and immune responses, CRISPR-Cas9 enables the rapid development of superior strains with stable and heritable traits. Case studies demonstrate successful gene editing applications that result in improved growth performance and enhanced disease resistance, thus reducing the need for antibiotics and supporting more sustainable aquaculture practices. However, challenges remain, including off-target effects, regulatory hurdles, and public acceptance. Ecological concerns, such as gene flow to wild populations, also warrant further investigation. Despite these challenges, CRISPR-Cas9 shows promise in transforming tilapia breeding programs by improving productivity and sustainability. As the technology advances and regulatory frameworks evolve, it is poised to have a long-lasting impact on the aquaculture industry.
. PDF(0KB)
. HTML
Associated material
. Readers' comments
Other articles by authors
. Chen Liang
. Yi Lu
. Rudi Mai
Related articles
. CRISPR-Cas9
. Gene editing
. Tilapia
. Growth enhancement
. Disease resistance
Tools
. Email to a friend
. Post a comment